Isolate | Rifampicin |
bVancomycin |
bMetronidazole |
cMoxifloxacin | Erythromycin |
---|
DSM 27638 |
a0.004 | S (0.5) | S (0.38) | R (>32) | R (>256) |
DSM 27639 | S (0.003) | S (0.75) | S (0.25) | S (2) | R (>256) |
DSM 27640 |
a0.004 | S (0.38) | S (0.25) | R (>32) | R (>256) |
DSM 27543 | S (0.003) | S (0.5) | S (0.25) | S (2) | R (>256) |
DSM 27147 |
a0.004 | S (0.5) | S (0.38) | R (>32) | R (>256) |
- May be tested for epidemiological purposes only (ECOFF 4 mg/L (EUCAST Clinical Breakpoint Table v. 7.1.). DSM 27543 (630) and DSM 27147 (R20291) served as controls
- MIC given in mg/mL, S sensitive, R resistant
-
aNot used clinically. May be tested for epidemiological purposes only (ECOFF 0.004 mg/L). Vancomycin: R > 2 mg/L. Metronidazole: R > 2
-
bThe breakpoints are based on epidemiological cut-off values, which distinguish wild-type isolates from those with reduced susceptibility
-
cNot used clinically